ERBB2 and breast cancer: Additionally, a randomized trial with metformin monotherapy in early stage breast cancer is ongoing (NCT01101438)3, as well as a trial combining metformin with neo-adjuvant chemotherapy in HER2+ breast cancer (NCT03238495).4